Article
MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.
Oncotarget - 6 Dec 2016
Menezes Mitchell E, Shen Xue-Ning, Das Swadesh K, Emdad Luni, Sarkar Devanand, Fisher Paul B
Abstract excerpt
Epithelial-mesenchymal transition (EMT) is one of the decisive steps regulating cancer invasion and metastasis. However, the molecular mechanisms underlying this transition require further clarification. MDA-9/syntenin (SDCBP) expression is elevated in breast cancer patient samples as well as cultured breast cancer cells. Silencing expression of MDA-9 in mesenchymal metastatic breast cancer cells triggered a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
